Booth 17155, McCormick Place
May 30 - June 3, 2025
OncoTarget®500
Comprehensive Genomic Profiling Panel
OncoTarget® Myeloid68
An NGS-Based Test for Myeloid Leukemia
OncoCore™
Because Waiting Shouldn't Be Part of Your Oncology Plan
When cancer is diagnosed, finding treatment options is the top priority
OncoTarget® Series is our comprehensive genomic profiling solution to identify targeted immunotherapies
for advanced cancers – solid tumors or leukemias.
for advanced cancers – solid tumors or leukemias.
Available in 7-10 business days
FDA-Cleared (510k) test
Clear insights into therapy options
First FDA-Cleared IVD Comprehensive Genomic Profiling Panel
Fast
Proven
Actionable
Test menu options for those products
505-gene panel + MSI & TMB
for advanced solid tumors
for advanced solid tumors
68-gene panel for myeloid malignancies
Immunotherapy Biomarkers:
MSI, MMR, PD-L1
32-gene panel
MSI, MMR, PD-L1
32-gene panel
